61
36
Growth Score
-21 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2613774
Invion is leading the global research and development of the Photosoft™ technology for the treatment of a range of cancers.
Thian Chew: Executive Chairman and CEO- Dr Greg Collier: Managing Director & Chief Executive Officer
About the Company
Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of the PhotosoftTM technology by licensor The Cho Group, which is based in Hong Kong. The Cho Group has funded and successfully commercialised a number of unique, advanced technologies. Invion has an agreement with The Cho Group to conduct the clinical
development of the PhotosoftTM technology globally. The Cho Group provides non-dilutive funding for the research into and clinical trials of PhotosoftTM via an R&D services agreement with Invion. The provision of non-dilutive funding is part of a global development strategy for PhotosoftTM.
